|
|
|
| Curative Effect of Shugan Jieyu Capsule Combined with Low-dose of Clomipramine on Depression Treatment |
| BAI Cun-hai, YU Li-yan |
| Department of Psychiatric Shiling Hospital of Zhangjiakou, Hebei 075131 China |
|
|
|
|
Abstract 【Objective】 To investigate the curative effect of Shugan Jieyu capsule combined with clomipramine in the treatment of depression. 【Methods】 A total of 96 patients with depression who were admitted to our hospital from October 2016 to October 2017 were divided into the control group and the experimental group according to random number table method. There were 48 patients in the control group and 48 patients in the experimental group. Patients in the control group were treated with clomipramine tablets at conventional dose, while patients in the experimental group were treated with Shugan Jieyu capsules combined with low-dose of clomipramine tablets. Both groups of patients were treated for 8 weeks. The Hamilton Depression Self-rating Scale (HAMD), and Ability of Daily Living Scale (ADL) were observed before and after treatment. 【Results】 The HAMD scores of the control group and the experimental group before treatment were (27.41±2.73) points and (28.19±2.58) points, respectively. After treatment, the HAMD score of the control group was 18.35±2.49 and the score of the experimental group was 9.82±2.16 , which showed lower than before treatment. The differences were statistically significant (t=3.266, P=0.002<0.05). The incidence of total adverse reactions in the control group was 29.17% (5/48) while the incidence of total adverse reactions in the experimental group was 10.42% (14/49). The difference between the two groups was statistically significant (χ2=5.315, P=0.021<0.05). The ADL scores of the control group and the experimental group were 41.23±22.25 and 42.68±23.09, respectively. After treatment, the HAMD scores of the experimental group and the control group were 62.83±19.14 and 53.47±21.97, respectively,. which were higher than before treatment. The difference was statistically significant (t=-2.226, P=0.028<0.05). 【Conclusion】 Shuganjieyu Capsules combined with clomipramine have a good effect in the treatment of depression, which significantly improves the clinical symptoms of depression in patients, reduces the adverse reactions during treatment, and promotes the daily living ability of patients.
|
|
Received: 16 March 2018
|
|
|
|
|
|
[1] 和昱辰.抑郁症临床研究进展[J].国际检验医学杂志,2013,34(7):832-834.
[2] 王云琼,何影.帕罗西汀片和氯米帕明片治疗抑郁症的临床研究[J].中国临床药理学杂志,2017,33(15):1409-1411.
[3] 李春芳.舒肝解郁胶囊与氟西汀胶囊治疗血管性抑郁症对照研究[J].精神医学杂志,2014,27(6):462-463.
[4] 雷旭伟,应益飞.舒肝解郁胶囊与盐酸文拉法辛胶囊治疗抑郁症的疗效比较[J].中国药师,2016,19(4):726-727.
[5] 李清伟,姚军,吴文源等.舒肝解郁胶囊剂量加倍治疗中度抑郁症的随机、双盲、平行对照、多中心临床研究[J].中国神经精神疾病杂志,2016,42(10):580-585.
[6] 李春芳.舒肝解郁胶囊与氟西汀胶囊治疗血管性抑郁症对照研究[J].精神医学杂志,2014,27(6):462-463.
[7] 李永涛,文军,李淼等.米氮平联合舒肝解郁胶囊治疗卒中后抑郁疗效观察[J].河北医药,2015,37(7):1037-1040.
[8] 黄勤,黄慧民,刘莹,等.黛力新联合舒肝解郁胶囊治疗功能性消化不良的临床观察[J].环球中医药,2013,6(z2):107-108.
[9] 谢芳.舒肝解郁胶囊治疗冠心病合并抑郁症的疗效观察[J].中西医结合心脑血管病杂志,2014,12(2):164-165.
[10] 肖迎光,柯春兰.舒肝解郁胶囊联合舍曲林治疗老年抑郁症的临床疗效观察[J].中医药学报,2014,42(2):118-120.
[11] Hazari H, Christmas D, Matthews K,et al. The clinical utility of different quantitative methods for measuring treatment resistance in major depression[J].J Affect Disord,2013,150(2):231-236.
|
| [1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2018, 35(9): 1745-1747. |
|
|
|
|
2019, Vol. 36 
